Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs -60.00% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 291.18% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 11.11% vs 50.00% in Mar 2025
Compare Balance Sheet Results of Omkar Pharmachem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.08
23.82
-13.74
-57.68%
Share Warrants & Outstandings
Total Reserve
26.56
-161.97
188.53
116.40%
Shareholder's Funds
36.64
-138.14
174.78
126.52%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
79.93
-79.93
-100.00%
Secured Loans
0.00
48.22
-48.22
-100.00%
Unsecured Loans
0.00
31.71
-31.71
-100.00%
Deferred Tax Assets / Liabilities
-0.00
2.99
-2.99
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.78
-1.78
-100.00%
Total Non-Current Liabilities
-0.00
36.48
-36.48
-100.00%
Current Liabilities
Trade Payables
0.01
56.90
-56.89
-99.98%
Other Current Liabilities
0.04
8.37
-8.33
-99.52%
Short Term Borrowings
0.00
107.98
-107.98
-100.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.05
173.25
-173.20
-99.97%
Total Liabilities
36.69
71.59
-34.90
-48.75%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.03
103.68
-103.65
-99.97%
Less: Accumulated Depreciation
0.03
74.23
-74.20
-99.96%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
29.44
-29.44
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
36.38
0.00
36.38
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
36.39
29.44
6.95
23.61%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
18.04
-18.04
-100.00%
Sundry Debtors
0.03
12.01
-11.98
-99.75%
Cash and Bank
0.22
4.36
-4.14
-94.95%
Other Current Assets
0.05
5.73
-5.68
-99.13%
Short Term Loans and Advances
0.00
2.00
-2.00
-100.00%
Total Current Assets
0.30
42.15
-41.85
-99.29%
Net Current Assets (Including Current Investments)
0.25
-131.10
131.35
100.19%
Total Current Assets Excluding Current Investments
0.30
42.15
-41.85
-99.29%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
36.69
71.59
-34.90
-48.75%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
91.47
-91.47
-100.00%
Book Value per share (adjusted)
36.34
-57.98
94.32
162.68%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs -60.00% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Annual - Investments
Investments 36.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 291.18% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 0.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.11% vs 50.00% in Mar 2025
